Note

美股异动 | 泛生子(GTH.US)涨超8%,肝癌早筛方法HCCscreen获美FDA突破性设备认定

Verified Media
· Views 41
美股异动 | 泛生子(GTH.US)涨超8%,肝癌早筛方法HCCscreen获美FDA突破性设备认定 © Reuters. 美股异动 | 泛生子(GTH.US)涨超8%,肝癌早筛方法HCCscreen获美FDA突破性设备认定

智通财经APP获悉,9月30日(周三)美股盘初,泛生子(GTH.US)股价大涨,截至北京时间21:38,该股涨8.66%,报10.54美元。

今日,泛生子宣布,其肝癌早筛方法HCCscreen已获美国FDA突破性设备认定(Breakthrough Device designation)。

Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.

FOLLOWME Trading Community Website: https://www.followme.com

If you like, reward to support.
avatar

Hot

No comment on record. Start new comment.